CClinicalTrials.gg
CompletedNCT06093295Updated Jan 9, 2025

Non-invasive Brain Stimulation and Injury Risk Biomechanics

An interventional study of Repetitive Transcranial Magnetic Stimulation (Theta Burst Stimulation) in Concussion, Mild, sponsored by University of Georgia. Completed at 1 site in United States. Open to participants aged 18 Years to 35 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-01-09.

Sponsored by University of Georgia · Not applicable, Interventional, and Prevention

From the registry’s dates

  • Primary completion was May 2024, 2 years 4 months ago, and no results have been posted to the registry.
Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Non-randomized
Ages
18 Years to 35 Years
Sex
All
01

Study summary

The goal of this clinical trial is to test the effects of repetitive transcranial magnetic stimulation (theta burst stimulation) on movement biomechanics (jump landing) among individuals with and without a concussion history. The main question it aims to answer is if theta burst stimulation to the left dorsolateral prefrontal cortex improves single- and dual-task jump landing reaction time and jump landing biomechanics compared to a control site (vertex) for individuals with and without a concussion history.

Participants will be asked to perform a jump landing before and after the experimental (left dorsolateral prefrontal cortex) and control (vertex) theta burst stimulation protocol. The researchers will compare individuals with and without a concussion history to see if the effects differ between groups.

Read the detailed description

The overall goal of the project is to determine how repetitive transcranial magnetic stimulation (theta burst stimulation) influences movement among individuals with and without a concussion history. The purpose of this study is prevention via improving injury risk biomechanics to reduce the risk of future musculoskeletal injury.

Participants will complete 2 testing sessions separated by a minimum of 7 days.

During the first testing session, participants will complete single-task serial subtraction, single- and dual-task jump landing, and a theta burst stimulation intervention. The jump landing will be completed before and after theta burst stimulation and under single- and dual-task (serial 7s) conditions. During the second testing session, participants will complete the jump landing before and after theta burst stimulation under single- and dual-task (serial 7s) conditions.

On both testing sessions, the symptom checklist and Tampa Scale of Kinesiophobia 11 (TSK-11) will be administered upon arrival to the lab (after informed consent on day 1), and immediately after repetitive transcranial magnetic stimulation. The Godin Leisure Activity Questionaire will be administered on both days before the jump landing. The NASA Task Load index will be administered on both days immediately after the completion of every cognitive and motor task.

At the end of the second day of testing, the participants will be asked which day the participants believed the participants received the experimental and control conditions of the theta burst stimulation intervention.

This is a single-blinded cross-over design study. The participants will be unaware of when the participants receive the true (experimental) and control (placebo) theta burst stimulation intervention. Experimental (left dorsolateral prefrontal cortex) and control (vertex) conditions will be counterbalanced for the concussion history group. The control group will be matched to their respective concussion history group counterpart's counterbalanced order.

02

Conditions studied

  • Concussion, Mild

Browse trials for

Keywords

  • concussion
  • repetitive transcranial magnetic stimulation
  • mild traumatic brain injury
  • biomechanics
  • reaction time
  • theta burst stimulation
03

In context

Brain Concussion

530 studies on the registry are indexed under Brain Concussion; 152 are open to participants now.

This study's enrollment of 40 is below the median of 64 across 364 interventional studies indexed under Brain Concussion.

Browse Brain Concussion studies →

Lead sponsor

University of Georgia is the lead sponsor of 72 studies on the registry; 16 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 35 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

All participants

  • self-report to be physically active at least 90 minutes per week
  • aged 18-35 years old
  • self-report cleared for sports and physical activity

Concussion history group

  • self-report experiencing a concussion with the National Institute of Health common data element form

No concussion history group - self-report not experiencing a concussion with the National Institute of Health common data element form

Exclusion criteria

Exclusion Criteria:

All Participants

  • self-report attention deficit disorder and/or attention deficit hyperactivity disorder
  • self-report uncorrected vision problems (not included color blindness)
  • self-reported history of neurological disease
  • self-reported history of seizures/syncope or family history of epilepsy
  • self-reported history of frequent severe headaches or migraine.
  • self-reported history of respiratory or heart disease.
  • self-reported structural brain lesions (e.g., stroke)
  • self-reported increased intracranial pressure, such as after infarctions or trauma.
  • self-reported currently using antidepressants, neuroleptic medication, medication that lowers seizure threshold, or any other medication that would interfere with testing.
  • self-reported currently experiencing a high fever (day of testing; >102.9 degrees)
  • self-reported currently undergoing immunosuppressive therapy
  • pregnancy
  • metal anywhere in the head (except the mouth).
  • any electronic implant, such as a cardiac pacemakers, cochlear implant, or deep brain stimulator.
  • any implanted medication pump or intracardiac lines.
  • self-report not being cleared for sport/physical activity by a medical practitioner (i.e., must be cleared by a medical practitioner to participate if the participant had previous traumatic musculoskeletal injury)
  • students working directly in the PI's lab (concussion laboratory, biomechanics laboratory)
  • NCAA athletes

Concussion history group

  • ≥13 symptom severity on the Sport Concussion Assessment Tool (22 total symptoms are graded on a scale of 0-6. Any symptom with a score >0 [1-6], is summed to get symptom severity).
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Non-randomized
Intervention model
Crossover assignment
Masking
Single (Participant)
Enrollment
40 participants (actual)

Study arms

  • Experimental
    Left Dorsolateral Prefrontal Cortex (experimental)

    This is the experimental condition where participants will receive theta burst stimulation to the left dorsolateral prefrontal cortex.

    Device: Repetitive Transcranial Magnetic Stimulation (Theta Burst Stimulation)

  • Placebo comparator
    Vertex (control)

    This is the control condition where participants will receive theta burst stimulation to the vertex.

    Device: Repetitive Transcranial Magnetic Stimulation (Theta Burst Stimulation)

Interventions

  • DeviceRepetitive Transcranial Magnetic Stimulation (Theta Burst Stimulation)

    The repetitive transcranial magnetic stimulation device will generate successive magnetic pulses to the left dorsolateral prefrontal cortex (experimental condition) and the vertex (control condition). The theta burst stimulation protocol is as follows: * Total stimulation time \~190 seconds * Intensity: 80% of active motor threshold * 2 seconds train, repeated every 10 seconds * In every 2-second train, 3 pulses of stimulation are delivered at 50 Hz, repeated every 200 milliseconds (i.e., 5 Hz) for a total of 600 pulses

06

What researchers measure

Primary outcomes

  1. Reaction Time

    The time between the audible buzzer and the when sacral marker moves \>3 cm in the sagittal or transverse plane.

    Time frame: Immediately before and immediately after both theta burst stimulation conditions.

  2. Knee Flexion Angle

    The angle of the shank relative to the thigh in the sagittal plane (deg).

    Time frame: Immediately before and immediately after both theta burst stimulation conditions.

  3. Knee Abduction Angle

    The angle of the shank relative to the thigh in the frontal plane (deg).

    Time frame: Immediately before and immediately after both theta burst stimulation conditions.

  4. Hip Flexion Angle

    The angle of the thigh relative to the pelvis in the sagittal plane (deg).

    Time frame: Immediately before and immediately after both theta burst stimulation conditions.

  5. Hip Adduction Angle

    The angle of the thigh relative to the pelvis in the frontal plane (deg).

    Time frame: Immediately before and immediately after both theta burst stimulation conditions.

  6. Trunk Flexion Angle

    The angle of the trunk relative to the lab in the sagittal plane (global axis system; deg).

    Time frame: Immediately before and immediately after both repetitive theta burst stimulation conditions.

  7. Trunk Lateral Bending Angle

    The angle of the trunk relative to the lab in the frontal plane (global axis system; deg)

    Time frame: Immediately before and immediately after both theta burst stimulation conditions.

Secondary outcomes

  1. NASA Task Load Index

    The NASA Task Load Index is abbreviated NASA-TLX. The NASA-TLX is a self-reported assessment to assess the workload and effort of a given task. There are 6 domains (mental demand, physical demand, temporal demand, performance, effort, and frustration) each scored on a scale of 0 to 20. A score of 0 indicates "very low", and a score of 20 indicates "very high". The raw scores will be summed together for analysis. Higher scores indicate greater workload and effort. The NASA-TLX will be analyzed as a continuous variable ranging from 0-120.

    Time frame: After every cognitive condition during the jump landing on both the experimental and control theta burst stimulation days.

  2. Tampa Scale of Kinesiophobia 11

    The Tampa Scale of Kinesiophobia 11 (TSK-11) is a self-reported assessment to assess the participant's fear of movement. The TSK-11 ranges on a scale from 11-44. Higher scores on the TSK-11 indicate a greater fear of movement. TSK-11 will be analyzed as a continuous variable ranging from 11-44.

    Time frame: Immediately before and immediately after the experimental and control theta burst stimulation.

07

Study locations

1 site
  • University of Georgia
    Athens, Georgia 30602, United States
08

References and documents

Publications

  • Huang YZ, Edwards MJ, Rounis E, Bhatia KP, Rothwell JC. Theta burst stimulation of the human motor cortex. Neuron. 2005 Jan 20;45(2):201-6. doi: 10.1016/j.neuron.2004.12.033. PubMed 15664172 ↗
  • Ngetich R, Jin D, Li W, Song B, Zhang J, Jin Z, Li L. Enhancing Visuospatial Working Memory Performance Using Intermittent Theta-Burst Stimulation Over the Right Dorsolateral Prefrontal Cortex. Front Hum Neurosci. 2022 Mar 17;16:752519. doi: 10.3389/fnhum.2022.752519. eCollection 2022. PubMed 35370586 ↗
  • Shumski EJ, Anderson MN, Oh J, Schmidt JD, Lynall RC. Computerized and functional reaction time in varsity-level female collegiate athletes with and without a concussion history. J Sci Med Sport. 2023 Mar;26(3):189-194. doi: 10.1016/j.jsams.2023.02.008. Epub 2023 Mar 3. PubMed 36906428 ↗
  • Lynall RC, Blackburn JT, Guskiewicz KM, Marshall SW, Plummer P, Mihalik JP. Reaction Time and Joint Kinematics During Functional Movement in Recently Concussed Individuals. Arch Phys Med Rehabil. 2018 May;99(5):880-886. doi: 10.1016/j.apmr.2017.12.011. Epub 2018 Jan 11. PubMed 29337022 ↗
  • Said S, Gozdzik M, Roche TR, Braun J, Rossler J, Kaserer A, Spahn DR, Nothiger CB, Tscholl DW. Validation of the Raw National Aeronautics and Space Administration Task Load Index (NASA-TLX) Questionnaire to Assess Perceived Workload in Patient Monitoring Tasks: Pooled Analysis Study Using Mixed Models. J Med Internet Res. 2020 Sep 7;22(9):e19472. doi: 10.2196/19472. PubMed 32780712 ↗
  • Chimenti RL, Post AA, Silbernagel KG, Hadlandsmyth K, Sluka KA, Moseley GL, Rio E. Kinesiophobia Severity Categories and Clinically Meaningful Symptom Change in Persons With Achilles Tendinopathy in a Cross-Sectional Study: Implications for Assessment and Willingness to Exercise. Front Pain Res (Lausanne). 2021 Sep 1;2:739051. doi: 10.3389/fpain.2021.739051. eCollection 2021. PubMed 35295417 ↗
  • Woby SR, Roach NK, Urmston M, Watson PJ. Psychometric properties of the TSK-11: a shortened version of the Tampa Scale for Kinesiophobia. Pain. 2005 Sep;117(1-2):137-44. doi: 10.1016/j.pain.2005.05.029. PubMed 16055269 ↗

Individual participant data

Plan to share: No — Master data files will be available upon reasonable request.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 9, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06093295
Lead sponsor
University of Georgia
Responsible party
Sponsor
First posted
Oct 23, 2023
Start date
Nov 3, 2023
Primary completion
May 30, 2024
Completion
May 30, 2024
Last update
Jan 9, 2025

Study contacts

Robert C Lynall, Phd, ATC
principal investigator · University of Georgia

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion